2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
FDA Comment Number : | EC2677 | |||||||||||||||||||||||
Submitter : | Dr. Rex Kochanski | Date & Time: | 12/06/2006 09:12:24 | |||||||||||||||||||||
Organization : | Dr. Rex Kochanski | |||||||||||||||||||||||
Category : | Academia | |||||||||||||||||||||||
Issue Areas/Comments | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
Please, do not continue producing vaccines using human fetal cells just because that's what's always been done. There are other options worth investigating that would not pose ethical and moral problems via cooperation, however remote, in the ending of an early stage of human life. Thank you for your attention. | ||||||||||||||||||||||||